13F-HR filed by SUPERSTRING CAPITAL MANAGEMENT LP
SUPERSTRING CAPITAL MANAGEMENT LP filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 28 holding rows worth $114,247,624.
- Accession
- 0001931118-24-000011
- Filer
- CIK 1931118
- Filed
- 2024-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 28 entries on the cover page, a total value of $114,247,624 stated on the cover page (in dollars after the unit check, H1), rows summing to $114,247,624 with VALUE read as dollars as filed, 13F file number 028-23866. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ZAI LAB LTD ADR | 98887Q104 | ADR | 626,932 | $15,134,138 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 215,798 | $11,394,134 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 1,348,546 | $11,246,874 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 227,047 | $9,965,093 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 949,522 | $9,732,601 | dollars as filed | |
| Instil Bio Inc | 45783C200 | COM NEW | 107,545 | $7,239,929 | dollars as filed | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 392,711 | $6,138,073 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 226,684 | $5,771,375 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 1,466,934 | $5,134,269 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 337,347 | $5,131,048 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 599,048 | $4,612,670 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 595,203 | $4,404,502 | dollars as filed | |
| NKARTA INC | 65487U108 | COMMON STOCK | 740,294 | $3,346,129 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 60,515 | $2,948,896 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 100,000 | $2,414,000 | dollars as filed | call |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 111,605 | $1,888,357 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 478,115 | $1,338,722 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 37,287 | $1,096,611 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 200,000 | $848,000 | dollars as filed | |
| BIOMEA FUSION INC | 09077A106 | CMN | 83,554 | $843,895 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 29,104 | $748,264 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 156,626 | $635,902 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 131,795 | $622,072 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 25,401 | $524,023 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 12,447 | $354,864 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 20,840 | $348,862 | dollars as filed | |
| LAKESHORE BIOPHARMA CO LTD | G9845F109 | COM | 307,920 | $212,157 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 33,824 | $172,164 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001931118-24-000011 | this filing | 2024-11-14 | acceptance time not in the bulk data set |